017550 — Soosan Cebotics Co Income Statement
0.000.00%
- KR₩116bn
- KR₩115bn
- KR₩198bn
- 75
- 70
- 33
- 65
Annual income statement for Soosan Cebotics Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | ARS | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 137,830 | 252,992 | 286,297 | 226,541 | 197,892 |
Cost of Revenue | |||||
Gross Profit | 30,375 | 48,799 | 64,140 | 52,296 | 48,216 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 132,639 | 239,901 | 264,910 | 206,990 | 185,817 |
Operating Profit | 5,190 | 13,092 | 21,386 | 19,550 | 12,075 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 5,071 | 14,175 | 20,268 | 19,186 | 12,686 |
Provision for Income Taxes | |||||
Net Income After Taxes | 4,032 | 11,393 | 15,749 | 16,873 | 9,226 |
Net Income Before Extraordinary Items | |||||
Net Income | 4,032 | 11,393 | 15,749 | 16,873 | 9,226 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 4,032 | 11,393 | 15,749 | 16,873 | 9,226 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 107 | 230 | 309 | 251 | 147 |
Dividends per Share |